Skip to content
10-K

Annual Report

Neurogene Inc. NGNE

0001404644-26-000019

← back to feed
Filed
Mar 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 18, 2026 15.57M sh
Shares Diluted FY 2025 · Dec 31, 2025 21.33M sh
Shares Diluted FY 2025 · Dec 31, 2024 17.57M sh
Capex FY 2025 · Dec 31, 2025 $1.18M
Capex FY 2025 · Dec 31, 2024 $808K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$77.17M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$70.6M
Short Term Investments FY 2025 · Dec 31, 2025 $165.17M
Short Term Investments FY 2025 · Dec 31, 2024 $175.82M
Cash And Equivalents FY 2025 · Dec 31, 2025 $103.85M
Cash And Equivalents FY 2025 · Dec 31, 2024 $136.59M
Stockholders Equity FY 2025 · Dec 31, 2025 $264.89M
Stockholders Equity FY 2025 · Dec 31, 2024 $310.38M
Stockholders Equity FY 2025 · Dec 31, 2023 $186.02M
Current Liabilities FY 2025 · Dec 31, 2025 $16.41M
Current Liabilities FY 2025 · Dec 31, 2024 $15.16M
Total Liabilities FY 2025 · Dec 31, 2025 $23.72M
Total Liabilities FY 2025 · Dec 31, 2024 $25.36M
Current Assets FY 2025 · Dec 31, 2025 $271.77M
Current Assets FY 2025 · Dec 31, 2024 $315.92M
Total Assets FY 2025 · Dec 31, 2025 $288.6M
Total Assets FY 2025 · Dec 31, 2024 $335.73M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.24
Eps Diluted FY 2025 · Dec 31, 2024 −$4.28
Eps Basic FY 2025 · Dec 31, 2025 −$4.24
Eps Basic FY 2025 · Dec 31, 2024 −$4.28
Sga Expense FY 2025 · Dec 31, 2025 $28.32M
Sga Expense FY 2025 · Dec 31, 2024 $22.61M
Rd Expense FY 2025 · Dec 31, 2025 $75.01M
Rd Expense FY 2025 · Dec 31, 2024 $60.92M
Net Income FY 2025 · Dec 31, 2025 −$90.35M
Net Income FY 2025 · Dec 31, 2024 −$75.14M
Operating Income FY 2025 · Dec 31, 2025 −$103.33M
Operating Income FY 2025 · Dec 31, 2024 −$82.61M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $925K